Find Funding Opportunities

Purpose. This Funding Opportunity Announcement (FOA) is designed to promote research on tumor microenvironment with the focus on understanding the role of host stroma in tumorigenesis and responses to treatment. Through this FOA, the National Cancer Institute (NCI) and National Institute of Neurological Disorders and Stroke (NINDS) invite cooperative agreement applications from groups of investigators interested in forming Research Centers serving as components of an interactive NCI Tumor Microenvironment Network (TMEN). The main scientific objectives of TMEN are: 1) to generate a comprehensive understanding of composition of the stroma in normal tissues as well as its roles in tumor initiation, progression, and metastasis; 2) to delineate mechanisms of tumor-stroma interactions in human cancer; and 3) to identify the mechanism(s) by which tumor stroma may affect responses to treatment. In addition to these general NCI priorities, NINDS is particularly interested in research programs relevant to primary brain tumors or peripheral nervous system tumors. TMEN members will be expected to participate in collaborative efforts (to be developed within TMEN) that are directed at: 1) developing resources and reagents critical to the analysis of the tumor microenvironment; 2) developing novel technologies for use in tumor microenvironment research; and 3) outreach activities to facilitate dissemination of such resources and technologies to the broader research community. TMEN infrastructure is expected to establish repositories of critical reagents, resources, and information as well as promote and facilitate interdisciplinary collaborations both within and outside the Network. Mechanism of Support. This FOA will utilize the U54 cooperative agreement mechanism.

Purpose: This Funding Opportunity Announcement (FOA) is an initiative of the NIH Blueprint for Neuroscience Research (http://neuroscienceblueprint.nih.gov), a trans-NIH partnership to accelerate neuroscience research. Sixteen Institutes and Centers (ICs) are participating in the Neuroscience Blueprint. Awards will be administered by the National Institute on Drug Abuse (NIDA) on behalf of the Neuroscience Blueprint. This FOA will support integrated research education and research training programs that provide interdisciplinary training in basic neuroscience and the theoretical and technological approaches of computational neuroscience. Mechanism of Support: This FOA will use the T90 mechanism that includes linked research education and research training programs. Applicants will submit a single unified grant application and if selected for funding, two separate awards will be issued, an R90-research education award and a T90-research training award, based on distinct research education and research training-related funding authorities. Each application:

The NINDS intends to fund a multi-site, multi-project network (Parkinsons Disease Biomarker Identification Network, or PD-BIN) devoted to identifying biological markers for PD risk, onset, and/or progression, in order to facilitate development of disease-modifying treatments. The purpose of this FOA is to solicit linked cooperative agreement (U01) applications for the establishment of a Clinical Coordinating Center (CCC) and a Data Coordinating Center (DCC). The PIs for the DCC and CCC must coordinate their submissions. The CCC will be responsible for the oversight of all aspects of subject recruitment and specimen acquisition, including the management of multiple clinical sites (to be identified by the CCC applicant), enrollment of a core cohort of newly diagnosed patients with PD and matched controls, and accurate collection of all clinical and biological data. The DCC will provide all data management aspects for standardized acquisition, quality control, dissemination and public accessibility. The CCC and DCC must be flexible enough to accommodate and support a wide range of future add-on research projects seeking to utilize and augment the core PD-BIN data. Individual hypothesis-driven studies are not a component of this FOA. It is anticipated that all data and biospecimens acquired will be used to create a publicly available resource for biomarker validation and discovery. The CCC and the DCC will be expected to advance the general scientific goal of identifying and validating useful PD biomarkers.

Purpose. This Funding Opportunity Announcement (FOA) issued by the Fogarty International Institute (FIC), the National Cancer Institute (NCI), the National Institute on Aging (NIA), the National Institute of Environmental Health Sciences (NIEHS), the Office of Dietary Supplements, Office of the Director (ODS), the National Eye Institute (NEI), the National Institute of Mental Health (NIMH), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) encourages Research Project Grant (R01) applications from institutions/organizations that propose to conduct basic biomedical research relevant to global health. This program is intended to promote productive development of foreign investigators from low- and middle-income countries (LMICs), trained in the U.S. or in their home countries through an eligible NIH funded research or research training grant/award. It is expected that this program will stimulate research on a wide variety of high priority health-related issues in those countries, and advance NIH efforts to address important global health issues. Mechanism of Support. This FOA will utilize the NIH Research Project (R01) grant mechanism. Funds Available and Anticipated Number of Awards. The total amount to be awarded is $325,000 and the anticipated number of awards is six. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award may also vary. The total amount to be awarded and the number of awards will depend upon the quality and costs of the applications received.

The National Institutes of Health (NIH), Defense Advanced Research Projects Agency (DARPA), National Science Foundation (NSF), United States Department of Agriculture (USDA) and the Department of Homeland Security encourage applications for the development of technologies that will advance the field of robotics. Scientific interests for this joint-agency FOA include, but are not limited to, research directed towards innovations or advancements in robotic technologies and devices for: Robotics for Home Healthcare, Personalized Care for Special-needs Populations, and Robotic Wellness/Health Promotion; Robot-Assisted Recovery, Rehabilitation, and Behavioral Therapy; High-throughput Robotics Technologies; Better Than Biology Actuators; Patient Mobility and Rehabilitation Robotics; Dexterous Manipulators with Tactile Feedback; Multi-Agent Command, Coordination, and Communication; Robotic Co-Worker Assistive Technologies; robotics to render improvised explosive devices safe; and robotics for cross border tunnels. Specific areas of interests under this FOA are described under the Research Objectives.

Purpose. This FOA issued by the Office of Strategic Coordination, National Institutes of Health, solicits grant applications from institutions/ organizations that propose to convert the International Knockout Mouse Consortiums knockout embryonic stem (ES) cell libraries (www.komp.org and www.eummcr.org), into mice, perform quality control (QC) on the imported materials and subsequent products, cooperatively send the mice to the successful grantees under RFA-RM-10-011 for phenotyping, and cryopreserve germplasm of those mice and send aliquots to the KOMP repository. The overall objective of this FOA is to generate the resources needed by NIH-funded Mouse Phenotyping Centers to produce functional information for each protein coding gene in the mammalian genome as described in RFA-RM-10-011. Mechanism of Support. This FOA will utilize the U42 award mechanism and runs in parallel with two additional FOAs that solicits applications under the U54 award mechanism (RFA-RM-10-012, RFA-RM-10-011). Funds Available and Anticipated Number of Awards. Up to $12.4 million in total costs per year for periods up to 5 years may be requested. It is anticipated that 1-3 awards will be made contingent upon receiving scientifically meritorious proposals.

Purpose. This FOA issued by the Office of Strategic Coordination, Office of the Director, National Institutes of Health, solicits grant applications from institutions/ organizations that propose to perform broad phenotyping of the International Knockout Mouse Consortiums (IKMC) mutant mice. The overall objective of this FOA is to produce functional information for each protein-coding gene in the mammalian genome. Mechanism of Support. This FOA will utilize the U54 award mechanism and runs in parallel with two additional FOAs that solicit applications under the U54 and U42 award mechanisms (RFA-RM-10-012, RFA-RM-10-013). Funds Available and Anticipated Number of Awards. Up to $7.4 million in total costs per year for periods up to 5 years years may be requested. It is anticipated that 2-4 awards will be made contingent upon receiving scientifically meritorious proposals.

Purpose. This FOA issued by the Office of Strategic Coordination, Office of the Director, National Institutes of Health, solicits grant applications from institutions/ organizations that propose to develop and implement a Data Coordination Center and Database (DCCDB) as part of the Knockout Mouse Phenotyping Project (KOMP2). The DCCDB will be funded primarily to develop, house, and maintain databases to track the progress of the pipelines for producing the knockout mice from ES cells, collect all phenotype data generated at the phenotyping centers, coordinate these efforts with the International Mouse Phenotyping Consortium (IMPC) and to deliver this information to the members of the KOMP2 research network, NIH staff, and the public via a single integrated web portal of phenotype data. Mechanism of Support. This FOA will utilize the U54 award mechanism and runs in parallel with two additional FOAs that solicit applications under the U54 and U42 award mechanisms (RFA-RM-10-011 and RFA-RM-10-013). Funds Available and Anticipated Number of Awards. Up to $1.5 million in total costs per year for periods up to 5 years years may be requested. It is anticipated that a single award will be made contingent upon receiving scientifically meritorious proposals.

Purpose. This funding opportunity announcement (FOA) solicits Research Conference Grant (R13) applications for scientific meetings aimed at building interdisciplinary research teams in basic behavioral and social science research (b-BSSR). Applicants must propose developmental activities (i.e., meetings/workshops) that will build the capacity of interdisciplinary teams to accelerate, expand, and/or strengthen fundamental knowledge in b-BSSR as relevant to the Nations health and well-being. Proposed interdisciplinary teams must include at least one investigator from the basic social and/or behavioral sciences, and must include investigators from at least one additional discipline. Applicants are encouraged to either: (1) accelerate, expand, and/or strengthen the scope of investigation of a specific b-BSSR research domain through the integration of disparate approaches from b-BSSR and allied disciplines; or (2) increase the sophistication of theoretical, methodological, and analytical approaches in b-BSSR. These goals may be accomplished by fostering the development of shared scientific terminology, approaches, and methodologies across disciplines in order to address a common b-BSSR research question. Investigators may submit applications to support multiple meetings over a period of up to two years. Mechanism of Support. This FOA will utilize the R13 grant mechanism. Funds Available and Anticipated Number of Awards. The NIH Basic Behavioral and Social Science Opportunity Network (OppNet) intends to commit approximately $325,000 in total costs (direct costs plus Facilities and Administrative [F&A] costs) in FY 2011 to fund four to six new grants in response to this FOA.

The Paul B. Beeson Patient-Oriented Research Career Development Award in Aging (K23) program provides three to five years of mentored career development support to clinically trained faculty members in strong research environments to enable them to gain skills and experience in patient-oriented research on aging under the guidance of a mentor or mentors, and to establish an independent program of research in this field. The program also includes an annual meeting that allows opportunities to partner with national mentors and fellow awardees Clinically trained professionals or individuals with a clinical degree who are interested in a career in basic science should refer to the Paul B. Beeson Clinical Scientist Career Development Award in Aging (K08) [RFA-AG-11-008]. Mechanism of Support This FOA will utilize the NIH Patient-Oriented Career Development Award (K23) award mechanism Funds Available and Anticipated Number of Awards. The FY 2011 anticipated amount is $1 million. The anticipated number of awards is 5 to 7. Budget and Project Period. Applicants may seek up to $200,000 (direct costs) per year. Direct costs requested across all years may be no more than $600,000 for three year awards; $700,000 for four year awards; and $800,000 for five year awards. Awarded amounts may be significantly lower than these amounts. Although the financial plans of NIA, NIMH and NINDS provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications.